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~he 'potential role of integrins in the epidermotropism. of the 
ypI.cal lymphocytes of Sezary syndrome was studied by 
rOll1to~ing the expression of a and {J chains and their major 
Iga~ds In skin biopsies and peripheral blood cells in patients 
at .ddferent progression stages. Most mononuclear cell inte-
fnns were also detected on infiltrating cells including the 
I~kocyte complex CDll/CDl8, a4{Jl, and their ligands, 
AM-l and VCAM-l. Conversely, a6 and {J4 were present 
anI . Y 111 epidermal basal cells . Mononuclear infiltrates of SS 
were positive for both a3 and a5 chains, whereas in inflam-hatory cutaneous diseases only a5 was expressed, indicating 
t t a major feature of Sezary cells is the unique expressio 
°h Q3jJ1. Significant changes of a3{Jl were monitored in 
t e follow-up of Sezary patients and correlated with the 
results of the therapy. The heterodimer al{Jl was absent 
from mononuclear cells except in one case. Among matrix 
molecules, laminin and type IV collagen displayed a pattern 
similar to that of the controls, whereas fibronectin and tena-
scin deposition were apparently increased. Circulating 
Sezary cells, both at diagnosis and during follow-up, were a3 
and a5 negative and failed to acquire these adhesion mole-
cules after mitogenic stimulation. We propose that the ex-
pression of a3{J1 is a distinguishing feature of skin-infiltrat-
ing Sezary cells and may be related to their epidermotropism. 
It could also be adopted as an additional parameter of the 
progression and therapeutic stage ofSezary syndrome.] Invest 
DermatoI99:151-159, 1992 
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S ezary syndrome (SS) is a cutaneous T-cell lymphoma, characterized by exfoliative erythroderma, generalized lymphadenopathy, and atypical mononuclear cells (Sezary cells, SC) in the peripheral blood [1,2]. A dense ~ bandlike infiltrate of atypical lymphocytes with cerebri-t m nuclei in the dermis and a single-cell epidermotropism are 
(~stlUctlVe histologic features. Clusters of cerebriform lymphocytes 
ntner's microabscesses) are not uncommon [3,4] . 
Ie molecular mechanisms driving these atypical lymphocytes 
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to the skin and inducing their migration across the basement mem-
brane into the epidermis are not known. A major role may be played 
by adhesion molecules involved in recognizing basement mem-
brane components and, notably, by the integrin receptors expressed 
on the lymphocyte surface (for review see [5]). 
Integrins form a family of cell-to-matrix and cell-to-cell adhesion 
glycoprotein receptors, and are commonly divided into subfamilies, 
according to a shared P subunit combined with specific a subunits 
(for a recent review see [6]) . The integrins expressed by bone 
marrow-derived cells belong to three subfamilies: 1) Pl integrins 
or VLA subfamily [7]; 2) P2 integrins or leukocyte integrins [5]; and 
3) p3 integrins or cytoadhesions comprising the major platelet com-
plex IIbIIIa anJ the vitronectin receptor [8]. An additional p chain 
(fJP or P7) has been described in lymphocytes homing to Peyer's 
patches [9]. Only pl and P2 integrins are normally expressed on 
blood-derived mononuclear cells (MNC) [10] . a4pljaSpl and 
aLp2 (LFA1, CDllajCD18) are present on normal lymphocytes 
infiltrating the dermis, whereas aMp2 (MAC1, CDllbjCD18) 
and aXp2 (plS0,9S or CDllcjCD18) are found on dermal and 
subepidermal monocytes and macrophages [11]. 
Only aLp2 and its major ligand ICAM-1 are directly involved in 
the epidermotropism ofT lymphocytes [12,13], whereas a4pl is a 
lymphocyte recirculation receptor that can bind VCAM-1 on endo-
thelial cells activated by inflammatory reactions [14-16]; this fea-
ture and its involvement in homotypic adhesion suggest some func-
tional redundancy with LFA-1 (for review see [5,17 ,18]). 
In this paper we have investigated the role of a spectrum of inte-
grin receptors potentially involved in the epidermotropism of the 
neoplastic lymphocytes typical ofSS. We report that infiltrating SC 
express both the integrins present on mononuclear inflammatory 
cells and the a3 and a~ chains of the P1 subfamily. However, only 
a3p1 seems to be pecuhar to Sc. Furthermore, a3 and as chains are 
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not present on circul ating SC and are not acquired after mitogenic 
stimulation. 
MATERIALS AND METHODS 
Tissues Biopsy samples were taken from 11 patients (two female 
and nine male) with SS. All patients presented exfoliative erythro-
derma with hyperkeratosis of palms and soles, onychodystrophy, 
generalized lymphoadenopathy, and > 10% (> 1000/mm3) atypi-
cal cerebriform peripheral blood lymphocytes . 
Two biopsies (pretreatment and when complete remission or 
partia l remission or progression occurred) were carried out in six of 
11 patients. 
Five biopsy specimens were taken from clinically normal skin 
from plastic surgery excisions. Specimens from 15 benign cutaneous 
diseases (eczematous erythroderma, five cases; psoriatic erythro-
derma, five cases; peritumoral infiltrate in basal cell carcinoma, five 
cases) were also used as controls. 
Isolation of Peripheral Blood Mononuclear Cells Peripheral 
blood mononuclear cells (PBMe) were isolated on a Ficoll-Hy-
paque density gradient. After washing three times with Hanks' 
balanced salt solution (HBSS) (GIBCO, Grand Island Co., NY), 
they were resuspended at a density of 5 X 106 cells/ml in RPM I 
1640 (GIBCO) supplemented with 5% heat-inactivated fetal calf 
serum (FCS). 
Cell Cultures MN C were cuI tured at a concentration of 2 X 105 
cells in RPMI 1640 medium supplemented with 5% FCS and i) no 
addition; ii) 1 % phytohemoagglutinin (PHA); iii) interleukin-2a 
(IL-2a) 50 Uljml; iv) PHA + IL2a; and v) Concanavalin A (ConA). 
Plates were incubated in a humified 5% CO2 atmosphere at 3rc 
for 48 h, 7 d, 14 d, and 30 d. 
Cell viability (trypan .blue exclusion assay) at 48 h and 7 d was 
> 90%, whereas at 14 d it was 50% and at 30 d it was 25%. 
Antibodies T he primary antibodies utilized in this study and the 
investigators who kindly provided them are specified in Table I. 
The monoclonal antibodies (MoAb) were used at a final concen-
tration of 40 J1g/ml, whereas the polyclonal antibodies were diluted 
to a final concentration of 10 J1g/ml. 
Indirect Im.munoperoxidase Technique Small skin samples 
were mounted in OCT 4583 embedding compound (Miles Scien-
tific, Naperville, IL), and frozen directly in a -70°C refrigerator. 
Frozen serial sections were cut at 6 J1m in a Leitz cryomicrotome, 
transferred onto microscope slides coated with poly-D-lysine 
(Sigma Chemical Company, St. Louis, Mo), air-dried, and stored at 
room temperature overnight. The samples were then fixed for 
10 min in a chloroform-acetone mixture (1 : 1), ai r-dried, and incu-
bated for 10 min in phosphate-buffered saline (PBS) supplemented 
with 1 % serum of the same species as the secondary antibody. Serial 
sections were overlaid with 50 J1l of different antibodies at a con-
centration of 10 -40 J1g/ml in HBSS and incubated at room temper-
ature for 30 min in a moist chamber. After a thorough wash in PBS, 
the sections were incubated with the appropriate biotinylated sec-
ondary antibodies, and processed for the ABC method (avidin-bio-
tin peroxidase complex) using the Vectastain ABC Kit (Vector Labo-
ratories Incorporated, Burlingame, CA) . After several washes, 
100 J11 substrate were added for 5 to 10 min, prepared as follows . 
Five milligrams 3-amino, 9-ethylcarbazole (Sigma Chemical Com-
pany) were dissolved in 1 ml N,N-dimethylformamide (Merck, 
Darmstad, FRG) supplemented with 9 ml 100 mM sodium acetate, 
pH 5.2, and 100 J11 12% H 20 2 . All samples were counterstained 
with Mayer's hemalum solution, mounted in Kaiser's glycerol gela-
tin (Merck) and examined with a Zeiss Axiophot photomicroscope 
equipped with planapochromatic lenses. 
Double-Label Imm.unofluorescence Staining Frozen sec-
tions were processed as described above and then incubated simulta-
neously with a mouse MoAb and a corresponding rabbit antibody. 
After the usual washing procedure, sections were incubated with 
flu orescein-tagged goat anti-mouse IgG and rhodamine-tagged 
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Table I. Monoclonal and Polyclonal Antibodies Against a and 
fJ Integrin Chains and ECM Proteins U sed in the Present Study 
Antibody Type Antigen C luster Source 
TS2/7 Mm a1 CDw49a M. H emler' [20] 
12F1 Mm a2 CDw49b V. Woods' [22] 
F1 Mm a3 L. Zardi' 
F2 Mm a3 L. Zardi' 
Ra3 Rp a3 G. Taroned 
B5G10 Mm a4 CDw49d M. Hemler' [21] 
SAM-l MM as CDw4ge Immunotech 
MAR 6 Mm a6 CDw49f S. Menard' 
GOH3 Mm a6 CDw49f A. Sonnerbergf [23] 
A-lAS Mm P1 CD29 M . Hemler' [19] 
4B4 Mm Pl CD29 Coulter Immunology 
2F12 Mm aL CD tt a R. van Lier! 
Leu 15 Mm aM CD ttb Becton Dickinson 
Leu M 5 Mm aX CD 11c Becton Dickinson 
C LB-54 Mm P2 CD18 R. van Lier! 
MAR2 Rp p3 CD6 1 E. Dejanag [25] 
AA3 Mm P4 V. Quarantah [24] 
S3-41 Mm P4 V. Quaranta/' [24] 
4B9 Mm VCAM-1 J. Harlan' 
LB2 Mm ICAM-1 D akopatts 
anti-laminin Rp LM Sigma Chemical Co 
Coli type IV Rp COLL IV Heyl GmBH 
IST-9 MM FN L. Zardi ' [26] 
BC-2 Mm TN L. Zardi ' 
BC-4 Mm TN L. Zardi' 
---
• Dana Faber Cancer Institute, Boston, MA, USA. 
• University of California, San Diego, CA, USA. 
, 1ST, Genova, Italy. 
J Dipartimento di Genetica, Biologia e Chimica Medica, Universiti di Torino, Italy. 
' INT, Milano, Italy. 
f Central Laboratory of the Netherlands Red Cross, Amsterdam, The Netherlands. 
g Istituto Mario Negri, Milano, Italy. 
h Scripps Institute and Research Foundation, La Jolla, CA, USA. 
' University of W ashington, Seattle, USA. 
swine anti-rabbit IgG (Dakopatts, Copenhagen, Denmark) and 
mounted as above. Observations were carried out in an Zeiss AxIO-
phot photomicroscope equipped for epifluorescence. 
Fluorescence-Activated Cell Sorter (FACS) Analysis 1111-
munofluorescence was performed by incubating 200 J1l cell suspen-
sion with 5 J1l MoAb for 30 min in an ice bath. Cells were then 
washed twice with HBSS, resuspended in medium, and incubat.ed 
with 100 J1l fluorescein-labeled goat anti-mouse immunoglobu\!nj 
After an additional 30-min incubation on ice, they were washN twice, resuspended in 100 J1l PBS, and examined on a FACSCA 
(Becton-Dickinson, Mountain View, CA). . 
The phenotype of T-cell infiltrates was examined by stain1l1~ 
with anti- T-cell antibodies Leu-1 (CD 5), Leu-3 (CD 4), Leu-
(LAM-1) , Leu-9 (CD 7), Il-2R (CD 25) (Becton Dickinson), Tee-
T9, Tec-TII (Technogenetics, Milano, Italia), TAl (CD 26, anti; 
DPP-IV) (Coulter Corporation, Hialeah, FL) , and UCI-lL 
(CD45RO) (Dakopatts). 
The phenotype of resting and cultured PBMC was also deter-
mined. PBMC from all cases analyzed shoved the phenorypic pr~ 
fil e of helper/inducer T cells: CD2+, CD3+, CD4+, CD5.' 
CD45RO+, CD45RA-, and CD8-. A loss of CD7 was found In 
five cases, and of Leu-8 in one. The same phenotype was found In 
the skin, where CD45RA did not exceed 3%. 
RESULTS 
The phenotype of the cellular infiltrate was de terminated in bod~ 
pathologic and control skin biopsies. The reactivity of24 monoclo 
nal and polyclonal antibodies directed against a and fJ integrld 
chains and the major ligands of integrin heterodimers was evaluate 5 
in 17 skin biopsies from 11 55 patients and compared to biopsle 
from normal and inflamed skin. f 
Comparative immunohistochemical analysis was particularly 0-
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p. St~Y:~1. Immunoperoxidase staining ofSezary syndrome skin biopsies; the staining was visualized using the avidin-biotin-conjugated peroxidase Vecta-
wher C kIt. Mononuclear infiltrating cells are a3 (A) and as (B) positive (bar, 25 11m). a3 is also found in lateral domains of basal epidermal cells (C), 
(F) (~as as IS not detectable on epidermal ce lls (D) (bar, 811m) . Positive and negative controls were provided by staining with antibodies against /31 (B) and a1 
ar, 25 /.1m). 
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Table II. a and P Integrin Chains Expression in Mononuclear Infiltrate from SS and Control Specimens· 
-Patients al a2 a3 a4 a5 a6 PI aL aM aX P2 VCAM-l rCAM-1 
Sezary syndrome: 1 ++ ++ ++ +++ +++ + ++ +++ 
2 + ++ + +++ +++ + + ++ +++ +++ 
3 ++ +++ +++ + + ++ +++ +++ 
4 ++ ++ + +++ +++ + ++ +++ 
5 + ++ +++ ++ + ++ NO NO 
6 + ++ ++ +++ +++ + ++ ++ +++ 
7 + ++ ++ ++ +++ +++ ++ ++ +++ 
8 ++ +++ +++ + ++ +++ +++ 
9 + ++ +++ +++ + ++ ND ND 
10 + ++ ++ +++ +++ + ++ +++ +++ 
11 ++ ++ + +++ +++ + ++ ++ ++ ++ 
Normal skin (5) ++ +++ +++ ++ 
Eczema (5) ++ + +++ +++ ++ 
Psoriasis (5) ++ + +++ +++ ++ + 
Basal cells carcinoma (5) ++ +++ +++ ++ 
• Percent positive cells: +++. 60-100%; ++. 30- 60%; +.10-30%; -. 0-10%; ND. not done. 
cused on the distribution of integrin a chains. Figure 1A shows that 
the MNC infiltrate in the dermis and epidermis of SS patients was 
highly positive for a3, whereas similar infiltrates from various in-
flammatory skin diseases were almost devoid of a3. The surface 
expression of as in the SS infiltrate was similarly high (Fig 1B) but 
also occurred in inflamed skin infiltrates. Minor differences in the 
rel ative number of as positive cells were observed in both types of 
disease. 
The fine surface topography of a3 and as positivity in SC was 
even better observed at higher magnification (Fig 1C,D); a3 was 
also found in lateral domains of basal epidermal cells (Fig. 1C), 
whereas as was not detectable (Fig 1D). 
Positive and negative controls were respectively provided by the 
immunoreactivity to P1 that was positive in the infiltrate and epider-
mis in both types of disease (Fig 1E), and by a1, which was found in 
blood vessels only (Fig 1F). An exception was provided by one case 
in which 10% of cerebriform C03+/C04+ intraepithelial lym-
phocytes expressed a1. Noteworthy is that this patient had a very 
high peripheral blood SC percentage and absolute number (60%; 
11,940), i.e., among the highest in all patients. 
The distribution of a and P integrin chains on MNC is reported 
in Table II . The a2 chain was negative on MNC both in SS and in 
the control group, and restricted to basal keratinocytes of epidermis, 
hair follicles, and sebaceous glands. The a4 chain was expressed by 
infiltrating MNC in all cases, whereas keratinocytes and other 
structures were always negative. a4 positive cells also expressed 
VCAM-1, the major ligand of this molecule. a6 was always absent 
from infiltrating cells, but present in the basal domain of basal 
keratinocytes, where it was associated with P4 as the heterodimer 
a6p4. p3 was also consistently absent from keratinocytes as well as 
from infiltrating MNC. 
The leukocyte complex COll/C018 shares the common P2 
chain (C018). It was only expressed on infiltrating cells. Hetero-
dimers aLp2 (LFA-1; COlla/COI8) and aXp2 (pI SO, 95; 
COllc/COI8) were expressed in all cases, whereas the integrin 
aMp2 (MAC-1; C011b/COI8), positive on dermal macrophages 
and monocytes, was found in less than 10% and in 15 - 20% of 
LeuM 1 + infiltrating cells in three cases. 
These data suggest that, although a3 immunoreactivity was nega-
tive in most infiltrating MNC from control specimens, it was asso-
ciated with about 30% of dermal and epidermal lymphoid cells in 
nine of 11 SS patients. Changes in a3 expression were found during 
the follow-up of individual patients. In patient 6, a further biopsy 
was taken on involvement of extracutaneous organs and increase of 
circulating Sc. On this occasion in this case the loss of a3 on 
infiltrating MNC paralleled the loss of epidermotropism (Fig 2A,B) 
and the increase of Ki67+ cells (from 1% to 50%). Conversely, 
increased a3 expression was observed in patients 4 and 11, where 
the disease was clinically stable and the histology showed only an 
increase of intraepithelial C04+ cells and Langerhans cells (Le). A 
negative pattern was observed in the very few residual mononuclear 
dermal cells of two patients who achieved complete remission. Oou-
ble immunofluorescence revealed, in all patients, a greater propor-
tion of a3 positive cells (80%) in the papillary dermis (at the der-
mal-epidermal junction) and among intraepidermal C03+/C04+ 
lymphocytes (Fig 2C,D). 
No modification in the immunocytochemical pattern of the 
other integrin molecules was found during follow-up, apart frorn a 
minor variation in the percentage of positive aXp2 and aMp2 ceIls, 
due to the different number of monocytes and macrophages in the 
skin infiltrate of individual patients. . 
The expression of ICAM-1, a known ligand ofLFA-1, was also 
investigated in nine patients. ICAM-l positivity was noted in all 
MNC in seven of nine cases and in keratinocytes in five cases. 
ICAM-1 positivity was focal and restricted to the areas of CD4+ 
cell epidermotropism. In the same cases keratinocytes expressed 
HLA-OR antigen with a more diffuse positivity pattern. The four 
keratinocyte ICAM-l negative cases did not express HLA-Dlt 
However T-cell epidermotropism was present in all. 
Lastly, in all biopsies the distribution of the major components oJ 
the extracellular matrix, namely, laminin, type IV collagen, an 
fibronectin, was investigated. Laminin (Fig 3A) and type IV coIlai 
gen (Fig 3B) had the same pattern of expression in SS and contr? 
specimens. On the other hand, a substantial increase in fibrone~t1n 
expression (Fig 3C) was observed in SS, mostly in cases expressing 
high a3. Tenascin (Fig 3D) was also highly represented in corre-
spondence with the SC dermal infiltrate, in keeping with its known 
expression in cutaneous tumors and reactive infiltrates. I 
The percentage of a3 and as positive epidermal and derrna 
lymphoid cells (approximately 30%) was in contrast with the nega-
tivity of peripheral blood cells. Both at diagnosis and during foi1o~­
up, a3 and as positive peripheral SC never exceeded 1- 2%. Th~ 
percentage did not differ from that of normal controls; a3 and Ci 
distribution in PBL from 10 cutaneous inflammatory diseases waS 
1.17% ± 1.1 and 1.42% ± 1.3, respectively. Activation antigefS 
(C02S, C030, C038, C071, and HLA-OR) anda1 were virtual ~ 
absent in resting peripheral SC; on the other hand, C025 an 
C071 were present in 30% of cells infiltrating the skin and ~ere 
located mainly (80%) in the papillary dermis and in the epithe/!u; 
with a pattern matching that of a3. C025 and C071 positive ce s 
were also C07 negative in five cases, denoting the SC phenotype~ 
Furthermore, PHA and PHA + IL2 in vitro stimulation of pe 
ripheral blood SC from five cases with a pure population evoked the 
expression of C02S and C071 in all cases (Table III) . 
To determine whether a3 and as are acquired after mi.roger 
stimulation, SC from two patients (1 and 11), representatlve 0 
different phenotypes (C07+, Leu-8+ and C07-, Leu-8-), we~= 
cultured in vitro up to 1 month; the phenotype of resting and CU 
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fl ' lo~~~~e 2. Immunoperoxidase staining of two skin biopsies obtained at diagnosis and during disease progression in one case ofSezary syndrome (A and B): the 
POsit' Q3 on mononuclear cells correlated with the loss of epidermotropism (bar, 50 11m). Double-label immunofluorescence localization of CD4 (C) and 0'3 
lYe mononuclear cells. The co-staining (D) shows that a major proportion of CD4+ lymphocytes expressed 0'3 (bar, 811m). 
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A B 
c 
Figure 3. lmmunoperoxidase staining ofECM proteins in 5ezary syndrome. Laminin (A) and type IV collagen (B) had the same pattern of expression both ill 
5S and in normal skin. A relevant increase of iibronectin (C) and tenascin (D) expression is observed (bar, 50,um). 
tured SC is reported in Table IV. As previously reported [27], a poor 
proliferative response to PHA and ConA was observed and SC failed 
to proliferate in the presence ofIL-2 alone (Fig 4A) . ai, a3, and as 
were not expressed after mitogenic stimulation to the same degree 
as they were in control cells (Fig 4B-D), despite the expression of 
activation antigens. Addition of exogenous IL2 to PHA'increased 
the proliferative response, but did not induce that expression of ai, 
a3, and as. By contrast, normal T lymphocytes cultured with mi-
togens acquired these molecules after 14 - 28 d, though resting cells 
did not express them. 
DISCUSSION 
SC show a peculiar tendency to migrate into the skin and infiltratE 
the epidermis. Their immunologic phenotype is very close to tha;~ 
mature T-helper lymphocytes (CD2+, CD3+, CD4+, CD ' 
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Table III. CD25 and CD71 Expressien en Resting and Cultured SC 
Resting Medium 
-
SC (0/0) CD25 CD71 CD25 CD71 
Case 1 98 1 2 Case 3 97 2 5 Case 6 95 1 2 Case 9 96 1 4 Case 11 92 0 2 
--
1 7 
2 4 
7 4 
6 15 
5 7 
FD8-); the enly surface phenetypic difference is the incenstant 
tOSS of CD7 [29] and Leu8 markers [28,29]. It is thus very impertant 
° tscever melecules and mechanisms leading to skin migratien 
an the ~ventual epidermetrepism ef SC. 
b Integnns are a class ef mediaters ef impertance in the recegnitien 
etween lymphecytes and the extracellular matrix, including the 
epjthehal basement membrane, as well as cell-cell interactien mele-~u es [30- 32,10,11]. The skin menenuclear infiltrate expresses the ~~Bgrins usually expesed en lymphecytes in reactive infiltrates, i.e., OX)' exLP2, and those typical ef menecytesjmacrophages, such as 
2 and exMp2. Thus, the whele CD18 complex plus ex4pl is 
eonstltu,rively expressed by infiltrating cells . Because ef the higher ~~~ortlon of menecytes and macrophages in SS, the expressien ef 
i iii 2 and exMP2 is slightly more substantial than in a plain reactive 
en trate. Moreover, a striking feature ef the SC phenetype is the 
expressIOn of two. integrins, ex3Pl and ex5pl. ex3Pl is apparently not 
i xpressed by lymphocytes feund either in nermal skin [11] or dur-n~cutaneeus inflammatory diseases. 
t he llltegrin ex3P1 (also knewn as VLA-3) is a cell-surface recep-l~r ~hat binds to. fib~enectin, lamin!n, and collagen type I and type 
rn [ 3 - 35] and IS lughly expressed m substrate-adherent cultures ef 
exany types ef human normal and turner cells. In the epidermis it is 
rn Posed On the plasma membrane ef basal and suprabasal cells 
poostly on lateral demains [36 - 39]. This informatien is also. sup-
sh rted by data ebtained on cultured keratinecytes [40]. It has been 
eeltn that ~pidermal ex3pl is also of particular importance in cell-
adh lllteractlOns. Its asseciatien with the basal surface of substrate 
flu erent tumor cells is a late event after days of culture under cen-of~~ bonditions [41]. The finding by Le Varlet et al [42] that 44% 
inv 1 ea: ex3 and 77% express ex5 indicates that they are prebably 
rna ° ved III LC migration and stabilization in the epidermis and 
inl playa part in the centact between LC and T cells by recegniz-
A. an as yet undefined ligand. 
On th llltriguing hypothesis is that ex3 and ex5 heterodimers, abse?-t 
bee e SC surface in their leukemic phase, are acquired in the skm 
tio:us~ o.f their possible role in cell-cell and cell-matrix interac-
hbc s. ~lS may involve specific ligands: in SS strongly expressed Withnd~n may pla~ ~ role, because it bi~ds both ex5 and ex3, thoug.h 
inte . I erent affil1ltles [43]. A new ligand fer cell adheSIOn via 
it is gnn ex3~1 has recently been identified and called epiligrin [44]: 
the fares.ent III mest epithelial basement membranes and located ~n 
nUna lUClda and may bind ex3Pl, mainly under patheleglc 
PHA IL-2 PHA+IL-2 
CD25 CD71 CD25 CD71 CD25 CD71 
22 48 11 13 52 52 
29 36 3 1 42 53 
31 10 10 5 57 27 
85 15 7 17 87 17 
35 22 12 7 60 44 
cenditions, and contribute to the epithelial trepism of sc. Other 
fibronectin-asseciated proteins, e.g., fibulin [45], may play reles that 
are still to be defined. 
Further ex3Pl ligands are two. major components of the basement 
membrane, such as collagen type IV and different variants of la-
minin er laminin-like molecules, e.g., meresin [46]. The epiderme-
tropism ef SC may be mediated by the interactien ef this integrin 
heterodimers with the ECM preteins. SC could indeed use mecha-
nisms ef migratien similar to. these adepted by neeplastic malignant 
cells in the metastatic pathway. 
Cell-adhesion melecules may be invelved in migratien ofleuke-
mic lymphecytes to the skin. For example, the dewn-regulatien of 
ICAM-l expressien en keratinocytes was associated with the less ef 
epidermetropism and increased aggressiveness in ene case of SS 
[12]. Furthermore, keratinocyte ICAM-l and MHC class II expres-
sion was feund to be induced by IFN-y and TNF, and much less by 
IL-l [12,47,48]. Hewever, keratinecyte ICAM-l expression dees 
net seem a prerequisite fer recruitment ef Iymphecytes into the 
epidermis, but more likely reflects the response to. IFN-y preduced 
by stimulated lymphoid cells. Recently Stoof et al [49] feund that 
keratinecytes, when beund by HUT cells, are activated and to tran-
scribe mRNA coding to. ICAM-1. 
Similarly, LFA-l expressien is greater in lew-grade than in high-
grade lymphemas [50]. The clinical observatien that increased epi-
dermetropism is accompanied by increased ex3 expressien, whereas 
that a loss ef epidermotrepism and extracutaneeus involvement are 
correlated with a loss of ex3 expressien suggests that ex3 plays a part 
in the skin heming mechanism typical ef Sc. 
In contrast to. normal PBL [7], a lewer propertion ef circulating 
SC express very late activatien antigens, such as VLA-l, VLA-3, and 
VLA-S, after mitegenic stimulatien theugh they may regularly ex-
press other activation antigellS. VLA-3 positivity in the skin infil-
trate, despite its absence en circulating SC, may be attributable to. 
unmasking or de nevo synthesis ef this melecule. Sequestration and 
proliferatien of the VLA-3 and VLA-5 peripheral blood subsets in 
the skin ceuld be an alternative hypothesis. VLA-5 is expressed at 
unifermly lew levels on normal naive cells but most ef the memery 
T cells express higher levels. VLA-3, altheugh to. a lesser extent, is 
increased in expressien en memory cells [51]. In CTCL the neo-
plastic T cells resemble antigen-cemmitted memory cells [52]. 
The recepters for fibronectin not only functien as adhesien mele-
cules able to. enhance the interaction between T-cell and extracellu-
Table IV. Phenetype of Resting and Cultured SC from Two Patients 
PHA + IL-2 
Resting Cells 48 h 7d 14 d 30 d 
Patient 1 Patient 11 Patient 1 Patient 11 Patient 1 Patient 11 Patient 1 Patient 11 Patient 1 Patient 11 CD 2 
95 CD 3 99 96 98 95 95 93 97 91 94 
CD4 97 97 98 95 96 97 97 95 97 94 
CD 5 92 98 97 90 94 88 95 87 93 90 
CD7 98 99 98 96 96 94 97 97 98 91 
CDS 71 2 71 4 87 2 85 2 90 3 leu 8 4 1 14 8 14 6 15 5 5 3 CD 26 72 8 72 10 82 8 61 6 54 4 
------=----
0 1 0 0 1 1 2 0 0 0 
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Figure 4. Proliferative activity after PHA stimulation (A), VLA-l (B), 
VLA-3 (C), and VLA-5 (D) expression after mitogenic stimulation in SC 
and normal control; the cells were cultured for 48 h, 7 d, and 14 d with 
medium alone, 1% PHA, 50UI/ml IL2a, PHA + IL2a. PBMC of two pa-
tients (1 and 11) was cultured, with fully comparable results. 
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lar matrix, but also deliver a costimulatory signal that enhances the 
proliferative responses [53]. . 
The unique expression of a3pl in SC may also serve diagnostiC 
and prognostic purposes and as an additional marker. Larger clinical 
investigation on different stages is needed to define its statistical 
value. 
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